X T L Biopharmaceuticals Ltd banner
X

X T L Biopharmaceuticals Ltd
NASDAQ:XTLB

Watchlist Manager
X T L Biopharmaceuticals Ltd
NASDAQ:XTLB
Watchlist
Price: 2.8 USD 4.09% Market Closed
Market Cap: $15.3m

Dividends

X T L Biopharmaceuticals Ltd
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
X T L Biopharmaceuticals Ltd

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
X T L Biopharmaceuticals Ltd

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

XTLB Price
X T L Biopharmaceuticals Ltd

Annual Price Range
2.8
52w Low
2.06
52w High
8.2
Price Metrics
Average Annual Return 0.5%
Standard Deviation of Annual Returns 69.32%
Max Drawdown -90%
Shares Statistics
Market Capitalization 18.9m USD
Shares Outstanding 5 449 060
Percentage of Shares Shorted 5.02%

XTLB Return Decomposition
Main factors of price return

Stock Splits

XTLB's latest stock split occurred on Mar 25, 2026

The company executed a 1-for-4 stock split, meaning that for every 4 shares held, investors received 1 new share.

Before the split, XTLB traded at 0.653 per share. Afterward, the share price was about 2.71.

The adjusted shares began trading on Mar 25, 2026. This was stock split number 3 in XTLB's history, following the previous one in Feb 10, 2017.

Pre-Split Price
2.612 0.653
Post-Split Price
2.71
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett